BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7982777)

  • 1. Control of malaria by drug-mediated iron deprivation.
    Hershko C; Cabantchik ZI
    Isr J Med Sci; 1994 Nov; 30(11):840-5. PubMed ID: 7982777
    [No Abstract]   [Full Text] [Related]  

  • 2. Malaria and iron: history and review.
    Weinberg ED; Moon J
    Drug Metab Rev; 2009; 41(4):644-62. PubMed ID: 19764831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 4. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of iron chelators in malaria.
    Mabeza GF; Biemba G; Gordeuk VR
    Acta Haematol; 1996; 95(1):78-86. PubMed ID: 8604591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity in vivo and in vitro of Plasmodium falciparum to chloroquine and amodiaquine in Bangangte (west Cameroon)].
    Agnamey PP; Leroy G; Kouamouo J; Brasseur P
    Bull Soc Pathol Exot; 1995 Mar; 88(4):149-51. PubMed ID: 8640075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iron chelation in antimalarial therapy].
    Pradines B; Millet J; Henry M
    Med Trop (Mars); 2003; 63(2):119-30. PubMed ID: 12910648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelation therapy for malaria.
    Gordeuk VR; Thuma PE; Brittenham GM
    Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mefloquine resistance in Plasmodium falciparum malaria].
    Garavelli PL
    Recenti Prog Med; 2003; 94(7-8):343. PubMed ID: 12868243
    [No Abstract]   [Full Text] [Related]  

  • 11. Malaria--a shadow over Africa.
    Miller LH; Greenwood B
    Science; 2002 Oct; 298(5591):121-2. PubMed ID: 12364787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine resistant Plasmodium falciparum in migrant population.
    Srivastava HC; Sharma SK
    Indian J Malariol; 2000; 37(1-2):39-42. PubMed ID: 11820081
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
    Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
    J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herba Artemisiae annuae tea preparation compared to sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial.
    Blanke CH; Naisabha GB; Balema MB; Mbaruku GM; Heide L; Müller MS
    Trop Doct; 2008 Apr; 38(2):113-6. PubMed ID: 18453510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin resistance in Plasmodium falciparum malaria.
    Htut ZW
    N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
    [No Abstract]   [Full Text] [Related]  

  • 16. Recrudescence of Plasmodium falciparum malaria contracted in Lombok, Indonesia after quinine/doxycycline and mefloquine: case report.
    Tish KN; Pillans PI
    N Z Med J; 1997 Jul; 110(1047):255-6. PubMed ID: 9251712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
    Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious diseases. Gates pledges 168 million dollars for malaria research.
    Enserink M
    Science; 2003 Sep; 301(5641):1828. PubMed ID: 14512593
    [No Abstract]   [Full Text] [Related]  

  • 20. Chloroquine resistant falciparum malaria--the Indian scene.
    Chogle AR
    J Assoc Physicians India; 1996 Oct; 44(10):677-8. PubMed ID: 9251337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.